Showing results (131-140 of 458) with videos related to
Sort By:
Pageof 46
Biochimica Et Biophysica Acta. Reviews on Cancer|September 6, 2024
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironmentJiwon Hong, Hyo Joon Jin, Mi Ran Choi, et al.Lung Cancer (Amsterdam, Netherlands)|June 2, 2009
A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancerSwan Swan Leong, Kam Weng Fong, Wan Teck Lim, et al.British Journal of Clinical Pharmacology|October 15, 2011
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patientsSin Chi Chew, Edwin Sandanaraj, Onkar Singh, et al.Pharmacogenomics|July 17, 2009
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecanJanelle M Hoskins, Gary L Rosner, Mark J Ratain, et al.Pharmacogenomics|August 29, 2015
Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associationsJohn Jack, Tammy M Havener, Howard L McLeod, et al.The Oncologist|March 3, 2012
Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6Rajesh R Kaldate, Abebe Haregewoin, Charles E Grier, et al.Proceedings of the National Academy of Sciences of the United States of America|July 30, 2004
Genome-wide discovery of loci influencing chemotherapy cytotoxicityJames W Watters, Aldi Kraja, Melissa A Meucci, et al.Journal of the National Cancer Institute|August 31, 2007
UGT1A1*28 genotype and irinotecan-induced neutropenia: dose mattersJanelle M Hoskins, Richard M Goldberg, Pingping Qu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian CancerSharon Marsh, Jim Paul, Cristi R King, et al.Personalized Medicine|May 18, 2018
Conference Scene: Is personalized medicine ready for prime time?William E Kraus, Susanne B Haga, Howard L McLeod, et al.Pageof 46